Altimmune to Participate at Two Upcoming Investor Conferences

Rhea-AI Summary

Altimmune (Nasdaq: ALT) has announced its participation in two upcoming investor conferences. The company will attend the Guggenheim Inaugural Healthcare Innovation Conference in Boston on November 11, 2024, featuring a fireside chat at 11:30 a.m. Eastern Time. Additionally, they will participate in the UBS Global Healthcare Conference in Rancho Palos Verdes on November 13, 2024, with a fireside chat scheduled for 9:30 a.m. Pacific Time and availability for one-on-one meetings. Both sessions will be accessible via webcast through the Events section of Altimmune's website.

News Market Reaction

+3.98%

1 alert

+3.98% News Effect

On the day this news was published, ALT gained 3.98%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in the following investor conferences:

• Guggenheim Inaugural Healthcare Innovation Conference (Boston, MA)
  Monday, November 11, 2024
  Fireside Chat at 11:30 a.m. Eastern Time

• UBS Global Healthcare Conference (Rancho Palos Verdes, CA)
  Wednesday, November 13, 2024
  Available for 1x1 meetings
  Fireside Chat at 9:30 a.m. Pacific Time

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Vipin Garg
President and Chief Executive Officer
Phone: 240-654-1450
ir@altimmune.com

Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com

Investor Contacts:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com

This press release was published by a CLEAR® Verified individual.

FAQ

When is Altimmune (ALT) presenting at the Guggenheim Healthcare Conference in 2024?

Altimmune will present at the Guggenheim Inaugural Healthcare Innovation Conference in Boston on Monday, November 11, 2024, at 11:30 a.m. Eastern Time.

What time is Altimmune's (ALT) fireside chat at the UBS Global Healthcare Conference 2024?

Altimmune's fireside chat at the UBS Global Healthcare Conference is scheduled for Wednesday, November 13, 2024, at 9:30 a.m. Pacific Time in Rancho Palos Verdes, CA.

How can investors access Altimmune's (ALT) conference presentations in November 2024?

Investors can access the webcasts of both conference presentations through the Events section of the Altimmune website.